Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Bristol-Myers Squibb’s Opdivo Secures Two New Approvals for Esophageal Cancer in China
January 24, 2025
Company
Drug
Henlius’ PD-1 Inhibitor HanSiZhuang Approved for First-Line SCLC Indication
January 24, 2025
Company
Medical Device
Agilis Robotics Completes Successful Animal Testing for Surgical Robot
January 24, 2025
Company
Deals
CARsgen and Huadong Medicine Partner to Commercialize BCMA CAR-T Product CT053 in China
January 24, 2025
Company
Deals
Tongshu Gene Partners with LC Gene to Distribute Gene Mutation Detection Kit in China
January 24, 2025
Company
Drug
3D Medicines’ 3D185 Receives Orphan Drug Designation for Gastric Cancer
January 24, 2025
Company
Drug
Ascletis Pharma Initiates Dosing in Phase I Trial for COVID-19 Treatment ASC11
January 24, 2025
Company
Deals
Base Therapeutics Secures Series A1 Funding to Advance Gene Editing Pipelines
January 24, 2025
Company
Deals
ConceMed Raises Pre-Series A Funding to Expand Digestive Endoscope Pipeline
July 8, 2025
Company
Drug
Luye Pharma’s Rykindo Receives FDA Approval for Schizophrenia and Bipolar I Disorder
January 24, 2025
Company
WuXi Biologics CEO Outlines Growth Amid Global Challenges at J.P. Morgan Conference
January 24, 2025
Company
Drug
Hengrui’s Generic Cyclophosphamide Capsules Approved by China’s NMPA
January 28, 2025
1
2
…
6
7
8
9
10
…
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?